India’s First Home Grown Electronic Witnessing System Launched At Oasis Hyderabad

S Singh
S Singh
· 3 min read
Witnessing System

Hyderabad July 25th  : Earlier this month, an awful news shocked the medical fraternity and the patients all over the globe. A US couple of Asian descent accused a California fertility clinic of an IVF mix up, leading them to have ‘wrong children’. They filed a lawsuit against the fertility clinic when they gave birth to two boys of Non-Asian traits. They also claimed that the DNA tests confirmed that the children were not related to the couple.

This kind of terrible mishap though rare, but may happen once in a blue moon, which can shatter the faith of the patients on medical sciences and destroy the reputation of a fertility clinic. We cannot accept this mishap when the solution to this problem is already there, and a fertility clinic did not care to embrace this technology for zeroing the chances of any mix-up.

World IVF Day, is celebrated to commemorate the birthday of the first test tube baby of the world Louise Brown who was born to this couple in Royal Oldham Hospital, United Kingdom. Today Louis Brown is proud mother of two sons who were conceived naturally and celebrating her 41st  Birthday. She is the first among 7 millions and still counting babies who have been born through IVF.

Talking on the occasion Dr Durga G Rao, Co- Founder and Medical Director of Oasis Centre for Reproductive Medicine stated that “When you start your treatment at Oasis Fertility, you can be reassured that we take adequate care of your oocytes, embryos and sperm. We are now equipped with a state-of-the-art Electronic Witnessing System (EWS) in our laboratory, designed to further safeguard the transparency and ensure that the process is undertaken without any human errors. This technology is India’s first home grown technology brought to us by ARTis Witness a pioneer in web based fertility treatment software with concept of Make in India.”

Electronic Witnessing System is a ‘track and trace’ system covering every single stage of the treatment process. This system improves traceability and quality control, while reducing laboratory-based risk. It tracks samples at predefined procedural steps in IVF laboratories to prevent mix-ups and provide an automated solution for mandatory double witnessing. This is achieved through assigning unique IDs and personal codes for all the samples. These codes, tagged to the samples, enable easy detection signals, identification, tracking and recording at every step. Only once the identity is confirmed through EWS, the Embryologist will proceed with insemination. In an unlikely event of sample mismatch, the system will alert the Embryologist preventing potential errors. The unique ID is automatically checked against the tagged embryo prior to the transfer. “

Adding to these points Dr Krishna Chaitanya – Scientific Head and Clinical Embryologist  of Oasis Centre for Reproductive Medicine said that “There are numerous benefits using the Electornic Witnessing System, there is automated cross checking and it ensures critical detection and prevention of human errors. It is safe and secure process which increases the confidence during every step of the cycle. EWS eliminates the potential risk of possible mismatching during sample handling and Vulnerability to human errors including check omission, check incomplete, involuntary automaticity, and non contemporaneous checking. It Prevents Embryologists from accidentally working on more than one patient’s gametes at a time and Marks each course step, ensuring prevention of omitting key tasks in the process.”

Read Next

Zydus Wellness net sales up by 62.1% for Q4 & 46.4% for FY 26  
News
May 19, 2026

Zydus Wellness net sales up by 62.1% for Q4 & 46.4% for FY 26  

Zydus Wellness Limited reported a consolidated growth of 62.1% in Net Sales, which stood at Rs. 14,761 million as compared to Rs. 9,106 million in the corresponding period of the previous year. The Company reported annual Net Sales of Rs. 39,400 million, with a y-o-y growth of 46.4% in FY 26. EBITDA for the period […]
Article by: IMT News Desk
Strides Pharma delivers strong FY26 performance with 50% PAT growth, ex‑US markets up 21%
News
May 19, 2026

Strides Pharma delivers strong FY26 performance with 50% PAT growth, ex‑US markets up 21%

Strides Pharma Science Ltd. reported a robust FY26 performance, with consolidated EBITDA rising to ₹9,253 crore and operational profit after tax (PAT) at ₹5,181 crore, up 50.3% year‑on‑year. The company’s ex‑US markets outpaced the rest of the business, posting 21% YoY revenue growth, while disciplined execution expanded full‑year EBITDA margin to 19%, up 140 basis points from FY25. […]
Article by: IMT News Desk
Annora Pharma Expands Collaboration with AI-Native Traceability Platform AltiusHub to Strengthen Global Drug Traceability
News
May 18, 2026

Annora Pharma Expands Collaboration with AI-Native Traceability Platform AltiusHub to Strengthen Global Drug Traceability

Annora Pharma, the formulations subsidiary of Hetero Group, has expanded its collaboration with AltiusHub. The company is deploying AltiusHub’s AI-native serialization, track & trace and regulatory compliance platform across its export operations. The deployment is designed to improve serialization efficiency by up to 45%. It will also strengthen operational visibility across Annora Pharma’s global supply […]
Article by: IMT News Desk
WFNS Innovation & Technology Committee Announces Partnership with Time Medical International Ventures (India) Pvt Ltd for First-in-Class Medical Technology Innovation
News
May 18, 2026

WFNS Innovation & Technology Committee Announces Partnership with Time Medical International Ventures (India) Pvt Ltd for First-in-Class Medical Technology Innovation

The World Federation of Neurosurgical Societies (WFNS) Innovation & Technology Committee has announced collaboration with Time Medical International Ventures (India) Pvt. Ltd (Time Medical India)., a wholly owned subsidiary of Fischer Medical Ventures Limited, marking a significant milestone in advancing innovation in global neurosurgical care. This marks the first time the Committee has formally partnered […]
Article by: IMT News Desk